Biotechnological advances in diabetic treatments have been increasing over the years. Some advances make finger-picking for blood a thing of the past, while others such as closed loop systems help automate insulin delivery. With more and more of these devices being introduced, treating diabetes is becoming much easier and safer. This blog will discuss two new devices: Continuous Glucose Monitoring Minus Calibration and the Closed Loop System.
Abbot Laboratories, a pharmaceutical company, has created what is called a Continuous Glucose Monitoring System (CGM), which requires no finger sticking or manual data entry. Blood glucose levels are read through a sensor worn on the back of the upper arm, and the sensor can be left in place for up to 10 days. Even non-diabetics have been using this device to measure their glucose intake. Dr. Ahn of UCLA medical school says that this technology, while aimed at type 1 diabetics will soon be embraced by the type 2 diabetes market.
Also known as an artificial pancreas, the closed loop system (CLS) helps makes type 1 diabetes more manageable by having a direct communication between the CGM and an insulin pump. The new technology replaces the “open-loop” concept that requires patients to access information from the CGM to determine how much insulin they need to inject themselves. This essentially automates the process for them, much like a self-driving car.
It is important for diabetics to consider their preferences and determine their comfort levels with technology. These new and improving medical devices are meant to help those with diabetes, however it still requires an in depth discussion between patient, family, and doctor to determine which one is best for you.